This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Genome and Company. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Kyoung Wan Yoon: Innovator in Cancer Treatment
Introduction
Kyoung Wan Yoon is a prominent inventor based in Seongnam-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in cancer treatment. His innovative work focuses on enhancing immune responses to combat cancer effectively.
Latest Patents
Kyoung Wan Yoon holds a patent for a pharmaceutical composition aimed at preventing or treating cancer. This composition comprises an LRIT2 inhibitor as the active ingredient. The invention highlights the potential of the LRIT2 inhibitor to increase the activity of immune cells, thereby serving as an immune enhancer. This innovative approach can effectively prevent or treat cancer by boosting the immunity of individuals.
Career Highlights
Kyoung Wan Yoon is associated with Genome and Company, where he continues to advance research in cancer therapies. His work is pivotal in developing new treatment options that leverage the body's immune system to fight cancer more effectively.
Collaborations
Kyoung Wan Yoon collaborates with notable colleagues, including Youn Kyung Houh and Bu-Nam Jeon. These partnerships enhance the research and development efforts at Genome and Company, fostering innovation in the pharmaceutical industry.
Conclusion
Kyoung Wan Yoon's contributions to cancer treatment through his innovative patent demonstrate his commitment to improving healthcare. His work exemplifies the potential of pharmaceutical advancements in enhancing immune responses to combat cancer effectively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile